Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Wellorithm

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Wellorithm a 51. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#10 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Wellorithm

#42 · Grade C · Watch List

Est. first month

Pricing not published

Get this deal Full Wellorithm review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 51 an est. $99/mo first month, with no teaser step-up baked in. Wellorithm isn't out of it: People who specifically want an oral dissolving tablet alongside brand-name pens and will complete an intake quiz before learning what any of it costs.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDWellorithm
Value Score89 (A)51 (C)
Est. first month$99/moPricing not published
Save vs brand-name~93%
Semaglutide$99/moPricing not published
Tirzepatide$139/moPricing not published
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 states49 states (not Louisiana)

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
28
bmiMD: 95. Wellorithm: 28.
84
No Teaser-Rate Bait
42
bmiMD: 84. Wellorithm: 42.
98
Nationwide Availability
92
bmiMD: 98. Wellorithm: 92.
94
Both Molecules
96
bmiMD: 94. Wellorithm: 96.
82
Easy Cancellation
58
bmiMD: 82. Wellorithm: 58.
70
Reputation
30
bmiMD: 70. Wellorithm: 30.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Wellorithm

Four compounded routes plus four branded pens — and not one price anywhere on the public site.

Why it's a deal

  • Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
  • Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
  • Sermorelin offered alongside the GLP-1 line
  • Serves 49 states, so most of the country is covered

The fine print

  • No price appears anywhere on the public site — /pricing returns 404 and every product CTA leads to an intake quiz, so no cost can be compared before signing up
  • The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says it is available in 49 states and cannot provide services in Louisiana
  • The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
  • "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim
Get the bmiMD deal Get the Wellorithm deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.